Clinical Trial Update: Thymoglobulin Induction Therapy With Minimal Immunosuppression and Evaluation of Allograft Status [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on thymoglobulin induction with minimal immunosuppression and assessment of allograft status; the study is terminated with posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunosuppression

Drugs mentioned

• Thymoglobulin (rabbit anti-thymocyte globulin)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Immunosuppression | Phase 4 | Status: TERMINATED | Results posted: 2016-02-01